capital partners: Live & Latest News Updates : Vimarsana.com
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]
Los-angelesCaliforniaUnited-statesVanda-pharmaceuticals-incJacobs-levy-equity-management-incNasdaqStonepine-capital-managementCapital-partnersAcadian-asset-managementVanda-pharmaceuticals-company-profileNews-ratings-for-vanda-pharmaceuticals-daily